-transparent.png){kind=logo}
A 500 mg L-Dopa administration in normal and cirrhotic subjects does not determinate a significant varation of plasma glucose and insulin level, while a peak plasma GH level in both cirrhotic and normal subjects occurred at 90' with a significantly greates values in cirrhotics. It is doubtful to affirm that a high plasma GH level is the only one factor which responsable of glucose intolerance in cirrhotic subjects, when there are many others factors contribute to it in synergic way. In order to elucidate the hypothesis on possible pathogenetic mechanism it is discussed some of our own experience and observations.
Related Publications
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
June 1975,
Revista clinica espanola,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
January 1979,
Endokrynologia Polska,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
March 1983,
Clinical endocrinology,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
December 1989,
Journal of endocrinological investigation,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
March 1977,
The Journal of clinical endocrinology and metabolism,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
July 1972,
Nihon Naibunpi Gakkai zasshi,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
December 1975,
Bollettino della Societa italiana di biologia sperimentale,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
May 1979,
Minerva medica,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
October 1990,
Regulatory peptides,
A V Greco, and
G Ghirlanda, and
G Fedeli, and
A Rebuzzi, and
L Altomonte, and
R Manna
April 1976,
Annals of surgery,
